Trial NCT05473715

View at ClinicalTrials.gov 
Org. Study IDs: 21912
Secondary IDs: 2022-000690-73

Last trial update was posted on 2023-09-01

MeSH Interventions

Aflibercept

MeSH Conditions

Macular Degeneration

Other Conditions

Neovascular (Wet) Age-related Macular Degeneration

Stopping Reasons

Study terminated due to administrative reasons not related to efficacy or safety.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID